Idiopathic pleuroparenchymal fibroelastosis

Idiopathic pleuroparenchymal fibroelastosis, often called PPFE for short, is a rare lung disease where scar tissue builds up in the upper parts of the lungs and in the lining around the lungs (called the pleura). The word 'idiopathic' means doctors do not yet fully understand what causes it in most people. Over time, this scarring makes the lungs stiff and smaller, which makes it harder to breathe. PPFE is considered a type of interstitial lung disease, a group of conditions that cause progressive lung scarring. The most common symptoms include shortness of breath, a dry cough, and chest pain, especially when breathing deeply. As the disease progresses, people often lose weight without trying, feel very tired, and may notice their chest shape changing — the upper chest can look flatter or narrower than normal. Lung function gradually declines over time. There is currently no cure for PPFE. Treatment focuses on managing symptoms, slowing progression where possible, and improving quality of life. Some patients may be considered for lung transplantation in advanced stages. Because PPFE is so rare, treatment approaches are still being studied, and care is usually managed by a specialist in rare lung diseases.

Bring these to your next appointment

• Q1.How certain are you that I have PPFE, and what tests were used to confirm this diagnosis?,Should I have genetic testing, and could this condition affect other members of my family?,What treatment options are available to me, and are there any clinical trials I could join?,How quickly do you expect my lung function to decline, and what signs should I watch for at home?,Am I a candidate for lung transplantation, and when should we start discussing that option?,What can I do — such as exercise, diet, or avoiding certain things — to help slow the disease?,What support services or patient groups are available to help me and my family cope with this diagnosis?

Common questions about Idiopathic pleuroparenchymal fibroelastosis